HomeMy WebLinkAbout08/19/2020 Agreement Kevin Madok, CPA
:
,e;, . M._ Clerk of the Circuit Court&Comptroller—Monroe County, Florida
DATE: October 16, 2020
TO: Bryan Cook, Director
Employee Services
FROM: Pamela G. Hancoc c .C.
SUBJECT: August 19th BOCC Meeting
Attached is an electronic copy of the following item for your handling:
CI Three-year Agreement with Capital Rx, Inc.,to provide Pharmacy Benefits
Management services and an Employer Group Waiver Program for employees, retirees, and
dependents beginning January 2, 2021; and the Business Associate Agreement.
Should you have any questions please feel free to contact me at(305) 292-3550.
cc: County Attorney
Finance
File
KEY WEST MARATHON PLANTATION KEY PK/ROTH BUILDING
500 Whitehead Street 3117 Overseas Highway 88820 Overseas Highway 50 High Point Road
Key West,Florida 33040 Marathon,Florida 33050 Plantation Key,Florida 33070 Plantation Key,Florida 33070
305-294-4641 305-289-6027 305-852-7145 305-852-7145
BUSINESS ASSOCIATE AGREEMENT
THIS BUSINESS ASSOCIATE AGREEMENT ("Agreement") is effective as of August 19,
2020 by and between Monroe County Board of County Commissioners ("Covered Entity") and Capital
Rx Inc. ("Capital Rx"). Covered Entity and Capital Rx are each a"Party"and collectively the "Parties."
RECITALS.
1. Covered Entity has engaged Capital Rx to provide certain functions, activities, and
services (collectively "Services") to Covered Entity as described in the Parties' PBM services
agreement("Services Agreement").
2. In order for Capital Rx to perform the Services required by the Service Agreement,
Covered Entity will make available and/or transfer to Capital Rx certain Protected Health
Information and Electronic Health Information (collectively, "PHI") that is confidential and must
be afforded special treatment and protection pursuant to the Health Insurance Portability and
Accountability Act of 1996 ("HIPAA") and its implementing regulations (45 C.F.R. Parts 160-
164) ("HIPAA Rules") (all as amended by the Health Information Technology for Economic and
Clinical Health Act, Division A of Title XIII of the American Recovery and Reinvestment Act of
2009,Public Law 111-005 (the "HITECH Act")).
3. Capital Rx will create, have access to and/or receive from Covered Entity (or on
behalf of Covered Entity) certain PHI that can be Used or Disclosed only in accordance with this
Agreement and the Privacy Rule.
4. Covered Entity and Capital Rx intend to protect the privacy and provide for the
security of PHI Disclosed to Capital Rx pursuant to this Agreement in compliance with HIPAA
and the HIPAA Rules.
5. As part of the Privacy Rule, Covered Entity must enter into a contract with Capital
Rx containing specific requirements as set forth in, but not limited to, Title 45, Sections
164.308(b), 164.314(a), 164.502(e), and 164.504(e) of the Code of Federal Regulations, and
contained in this Agreement,before Disclosing PHI to Capital Rx.
Therefore, in consideration of the mutual promises and obligations set forth in this Agreement
and the Services Agreement, and other good and valuable consideration, the receipt and sufficiency of
which is hereby acknowledged, Covered Entity and Capital Rx agree as follows:
ARTICLE I.
Definitions
1.1. Meaning of Terms.
(a) Breach Notification Rule means the Standards for Notification in the Case of Breach of
Unsecured Protected Health Information at 45 CY R Parts 160 and 164, as amended.
(b) Privacy Rule means the Standards for Privacy of Individually Identifiable Health
Information at 45 CFR Parts 160 and 164,as amended.
1
(c) Protected Health Information ("PHI") has the same meaning as the term "protected
health information" at 45 CFR § 160.103, limited to the information created or received
by Capital Rx from or on behalf of Covered Entity. References to PHI shall include
Electronic Protected Health Information ("ePHI").
(d) Security Rule means the Security Standards for Protecting Electronic Health Information
at 45 CFR Parts 160 and 164, as amended.
1.2. Other Terms. Other capitalized terms shall have the meaning ascribed to them in the
context in which they first appear. Terms used, but not otherwise defined, in this Agreement shall
have the same meaning as those terms in 45 CFR Parts 160, 162, and 164. Any reference to a
regulation or section in the Code of Federal Regulations shall include any corresponding regulation
subsequently issued regardless of the date of issue.
ARTICLE II.
General Terms
2.1. Interpretation of Provisions. In the event of an inconsistency between the provisions of
this Agreement and the mandatory terms of the HIPAA Rules (as may be expressly amended from
time to time by the U.S. Department of Health and Human Services ("HHS") or as a result of final
interpretations by HHS, an applicable court, or another applicable regulatory agency with authority
over the Parties),the HIPAA Rules shall prevail.
2.2. Provisions Permitted by HIPAA Rules. Where provisions of this Agreement are different
from those mandated by HIPAA or the HIPAA Rules, but are nonetheless permitted by HIPAA or the
HIPAA Rules,the provisions of the Agreement shall control.
2.3. Conflicts with Services Agreement. In the event of an inconsistency between the
provisions of this Agreement and the Services Agreement, the provisions of this Agreement shall
prevail.
ARTICLE III.
Obligations and Activities of Capital Rx
3.1. Limits on Use and Disclosure. Capital Rx agrees to not Use or further Disclose PHI
other than as permitted or required by this Agreement or as Required By Law.
3.2. Safeguards. Capital Rx agrees to use reasonable and appropriate administrative, physical
and technical safeguards with respect to ePHI to prevent Use or Disclosure other than as required by
this Agreement. Capital Rx will comply with applicable provisions of the Security Rule.
3.3. Report of Improper Use or Disclosure or of Security Incidents.
(a) Capital Rx agrees to report to Covered Entity any Use or Disclosure of PHI not provided
for by this Agreement, and any Security Incident, of which Capital Rx becomes aware.
(b) Notwithstanding the provisions of Section 3.3(a) above, The Parties agree that this
paragraph constitutes notice by Capital Rx to Covered Entity, with no further notice
required, of the ongoing occurrence of attempted but unsuccessful Security Incidents
including, but not limited to, pings and other broadcast attacks on Capital Rx's firewall,
port scans, attempts to log on a system or enter a database with an invalid password or
- 2 -
username, and denial-of-services attacks that do not result in a server being taken off-
line, provided these attempted Security Incidents do not result in actual unauthorized
access, Use, Disclosure, modification, or destruction of PHI or interference with an
information system.
3.4. Report of Breach of Unsecured PHI. Capital Rx shall notify Covered Entity of a Breach
of Unsecured PHI within seven (7) business days of when Capital Rx discovers the Breach. Capital
Rx will be deemed to have "discovered" a Breach as of the first day on which the Breach is known, or
by exercising reasonable diligence would have been known, to any person, other than the person
committing the Breach, who is an employee, officer, or other agent of Capital Rx. Capital Rx's
notification shall be in writing and shall identify each Individual whose Unsecured PHI has been, or is
reasonably believed by Capital Rx to have been, subject to the Breach. Capital Rx shall include the
following information in its notification of Breach to Covered Entity, or promptly thereafter as
information becomes available:
(a) A description of the Breach, including the date of the Breach and the date of the
discovery of the Breach, if known;
(b) A description of the types of Unsecured PHI that were involved in the Breach
(such as whether full name, social security number, date of birth, home address,
account number, credit card numbers, diagnosis, disability code or other types of
PHI were involved); and
(c) A description of what Capital Rx is doing to investigate the Breach, to mitigate
the harm to Individuals, and to protect against further Breaches.
3.5. Agents and Subcontractors. Capital Rx will ensure that any agent, including a
Subcontractor, to whom Capital Rx provides PHI received from, or created or received by Capital Rx
on behalf of, Covered Entity, agrees in writing to the same restrictions and conditions that apply
through this Agreement to Capital Rx with respect to PHI. The written agreement shall also require the
agent or Subcontractor to implement reasonable and appropriate administrative,physical, and technical
safeguards that reasonably and appropriately protect the confidentiality, integrity, and availability of
ePHI that it creates, receives,maintains, or transmits on behalf of Covered Entity.
3.6. Availability of Internal Practices, Books and Records. Capital Rx shall make internal
practices, books, and records relating to the Use and Disclosure of PHI received from, or received by
Capital Rx on behalf of, Covered Entity available to the Secretary in a time and manner designated by
the Secretary, for purposes of determining Covered Entity's compliance with the HIPAA Rules.
Capital Rx shall notify Covered Entity, in writing, of any request by the Secretary under this Section in
a manner that is consistent with its ethical duties of confidentiality and the attorney-client privilege.
3.7. Access to Records. Capital Rx shall provide access, at the request of Covered Entity, and
in the time and manner designated by Covered Entity, to PHI in a Designated Record Set to Covered
Entity or, as directed by Covered Entity, to an Individual, in order to meet the requirements under 45
CFR § 164.524 with regard to providing an Individual with a right to access the Individual's PHI. If
any Individual requests access to, or the release pursuant to an authorization or otherwise of, PHI
directly from Capital Rx or its agents or Subcontractors, Capital Rx shall notify Covered Entity in
writing within seven (7) business days of the request. Covered Entity shall have sole authority and
responsibility to approve or deny such a request, and shall notify Capital Rx, in writing, of its decision
to approve or deny any such request.
- 3 -
3.8. Amendments to PHI. Capital Rx agrees to make PHI in a Designated Record Set
available, in the time and manner designated by Covered Entity, for any amendments that Covered
Entity agrees to make pursuant to 45 CFR § 164.526, or to otherwise allow Covered Entity to comply
with its obligations under 45 CFR§ 164.526. If an Individual requests amendment of PHI contained in
a Designated Record Set directly from Capital Rx or its agents or Subcontractors, Capital Rx shall
notify Covered Entity in writing within seven (7) business days of the request. Covered Entity shall
have sole authority and responsibility to approve or deny such a request, and shall notify Capital Rx, in
writing, of its decision to approve or deny any such request.
3.9. Documentation and Accounting of Disclosures.
(a) Capital Rx shall document such Disclosures of PHI and information related to such
Disclosures as would be required for Covered Entity to respond to a request by an
Individual for an accounting of Disclosures of PHI under 45 CFR § 164.528. Such
documentation shall be kept regarding all Disclosures of PHI except the Disclosures
described in 45 CFR § 164.528(a)(1). For each such Disclosure, Capital Rx shall
document the following information: (i) the date of the Disclosure; (ii) the name of the
entity or person who received the PHI and, if known,the address of such entity or person;
(iii) a brief description of the PHI Disclosed; and (iv) a brief statement of the purpose of
the Disclosure that reasonably states the basis for the Disclosure.
(b) Capital Rx shall provide to Covered Entity or an Individual, in the time and manner
designated by Covered Entity, information collected in accordance with subsection (a) of
this Section of this Agreement, to permit Covered Entity to respond to a request by an
Individual for an accounting of Disclosures of PHI under 45 CFR § 164.528. If a request
for an accounting is delivered directly to Capital Rx or its agent or Subcontractor by an
Individual or a person other than Covered Entity, Capital Rx shall within seven (7)
business days of such request, forward it to Covered Entity in writing. Capital Rx shall,
unless otherwise directed by Covered Entity or as Required By Law, supply an
accounting of Disclosures of PHI only to Covered Entity.
3.10. Disclosure of Minimum PHI. Capital Rx shall comply with the minimum necessary
standard set forth in 45 CFR §164.502(b) when Using or Disclosing or requesting PHI from Covered
Entity or other third parry, and shall Use, Disclose, or request the minimum PHI necessary to
accomplish the intended purpose of the Use, Disclosure, or request.
3.11. Response to Subpoena. Capital Rx shall promptly notify Covered Entity if it receives a
subpoena or other legal process seeking the Disclosure of PHI. Capital Rx agrees to allow Covered
Entity to control the response to any such subpoena or legal process, so long as Covered Entity does so
in a reasonable and timely fashion that does not subject Capital Rx to legal prejudice.
3.12. Notification of Claims. Capital Rx shall promptly notify Covered Entity upon
notification or receipt of any civil or criminal claims, demands, causes of action, lawsuits, or
governmental enforcement actions arising out of or related to this Agreement or the PHI, regardless of
whether Covered Entity and/or Capital Rx are named as parties in such claims, demands, causes of
action, lawsuits, or enforcement actions.
- 4 -
ARTICLE IV.
Permitted Uses and Disclosures by Capital Rx
4.1. Use or Disclosure to Perform Functions, Activities, or Services. Except as otherwise
limited in this Agreement, Capital Rx may Use or Disclose PHI to perform those functions, activities,
or services that Capital Rx performs for, or on behalf of, Covered Entity, provided that such Use or
Disclosure would not violate the Privacy Rule if done by Covered Entity. Any such Use or Disclosure
shall be limited to those reasons and those persons and entities as necessary to meet Capital Rx's
obligations. In all circumstances, Capital Rx shall limit such Uses and Disclosures to the minimum
amount of PHI that is necessary to fulfill those obligations.
4.2. Appropriate Uses of PHI. Except as otherwise limited in this Agreement, Capital Rx may
Use PHI for the following purposes: (a)the proper management and administration of Capital Rx; (b)
to carry out the legal responsibilities of Capital Rx; (c) to report violations of the law to appropriate
Federal and State authorities consistent with 45 CFR § 164.5020)(1); or(d) as otherwise Required By
Law.
4.3. Appropriate Disclosures of PHI, Confidentiality Assurances and Notification. Except as
otherwise limited in this Agreement, Capital Rx may Disclose PHI to a third parry for the proper
management and administration of Capital Rx, or to carry out the legal responsibilities of Capital Rx,
provided that Disclosures are Required By Law, or Capital Rx obtains reasonable assurances from the
person to whom the information is Disclosed that it will remain confidential and Used or further
Disclosed only as Required By Law or for the purpose for which it was Disclosed to the person, and
the person notifies Capital Rx of any instances of which it is aware in which the confidentiality of the
information has been breached.
4.4. Data Aggregation Services. If Capital Rx provides Data Aggregation services, Capital
Rx may Use PHI to provide Data Aggregation services to Covered Entity as permitted by 42 CFR
§ 164.504(e)(2)(1)(B), except as otherwise provided by this Agreement.
ARTICLE V.
Obligations of Covered Entity
5.1. Notice of Privacy Practices. Covered Entity shall provide Capital Rx with the notice of
privacy practices that Covered Entity produces in accordance with 45 CFR § 164.520, as well as any
changes to such notice.
5.2. Change or Revocation of Permission. Covered Entity shall provide Capital Rx with any
changes in, or revocation of, permission by an Individual to Use or Disclose PHI, if such changes
affect Capital Rx's permitted or required Uses and Disclosures. Capital Rx shall comply with any such
changes or revocations.
5.3. Restrictions on Use or Disclosure. Covered Entity shall notify Capital Rx of any
restriction to the Use or Disclosure of PHI that Covered Entity has agreed to in accordance with 45
CFR§ 164.522. Capital Rx shall comply with any such restrictions.
5.4. No Request to Use or Disclose in Impermissible Manner. Except as allowed in Sections
4.2 and 4.3, Covered Entity shall not request Capital Rx to Use or Disclose PHI in any manner that
would not be permissible under the Privacy Rule if done by Covered Entity.
- 5 -
ARTICLE VI.
Term and Termination
6.1. Term. The Term of this Agreement shall be effective as of the date first documented
above, and shall terminate when all PHI provided by Covered Entity to Capital Rx, or created or
received by Capital Rx on behalf of Covered Entity, is destroyed or returned to Covered Entity.
6.2. Termination with Cause. Upon either Party's knowledge of a material breach by the other
Party,the non-breaching Parry, in its discretion,may take either or both of the following actions:
(a) Provide an opportunity (in a reasonable time frame determined by the non-breaching
Party) for the breaching Party to cure the breach or end the violation, and if the breaching
Party does not cure the breach or end the violation,terminate this Agreement; or
(b) Immediately terminate this Agreement.
6.3. Changes in Law. In the event of passage of a law or promulgation of a regulation or an
action or investigation by any regulatory body which would prohibit the relationship between the
Parties, or the operations of either Parry regarding the subject of this Agreement, the Parties shall
attempt in good faith to renegotiate the Agreement to delete the unlawful provision(s) so that the
Agreement can continue. If the Parties are unable to renegotiate the Agreement within thirty (30)
calendar days, the Agreement, and any other agreement or relationship between the Parties related to
the Services, shall terminate immediately upon written notice of either Party.
6.4. Effect of Termination.
(a) Except as provided in paragraph (b) of this Section 6.4: upon termination of this
Agreement for any reason, Capital Rx shall return or destroy all PHI received from
Covered Entity, or received by Capital Rx on behalf of Covered Entity. This provision
shall apply to PHI that is in the possession of Subcontractors or agents of Capital Rx.
Capital Rx shall retain no copies of the PHI.
6.5. Retention of PHI.
(a) In the event that Capital Rx determines that it is necessary to retain some or all of the PHI
to continue its proper management and administration or to carry out its legal
responsibilities, Capital Rx shall provide to Covered Entity written notification of such
need. Capital Rx may retain only the PHI that is necessary for Capital Rx to continue its
proper management and administration or to carry out its legal responsibilities, but
Capital Rx shall return or destroy all other PHI pursuant to Section 6.4(a). Capital Rx
shall not Use or Disclose retained PHI other than for the purposes for which the PHI was
retained and subject to the same conditions set forth in this Agreement that applied prior
to this Agreement's termination. Capital Rx shall return or destroy the retained PHI
pursuant to Section 6.4(a) when Capital Rx no longer needs it for its proper management
and administration or to carry out its legal responsibilities.
ARTICLE VII.
Miscellaneous
- 6 -
7.1. Assi n e. This Agreement shall be binding upon and inure to the benefit of the
respective legal successors of the Parties. Neither this Agreement nor any rights or obligations
hereunder may be assigned, in whole or in part,without the prior written consent of the other Party.
7.2. Amendment. The Parties agree to take such action as is necessary to amend this
Agreement from time to time as is necessary for Covered Entity to comply with the requirements of
HIPAA and the HIPAA Rules.
7.3. Re u�ry References. A reference in this Agreement to a section in the HIPAA Rules
means the section as in effect or as amended, and for which compliance is required.
7.4. Entire Agreement. This document,together with any written schedules, amendments and
addenda, constitute the entire agreement of the Parties and supersedes all prior oral and written
agreements or understandings between them with respect to the matters provided for herein.
7.5. Governing Law. This Agreement shall be governed by and construed in accordance with
the laws of the State of Florida to the extent that the provisions of HIPAA or the HIPAA Rules do not
preempt the laws of the State of Florida.
7.6. Modifications. Any modifications to this Agreement shall be valid only if made in
writing and signed by a duly authorized agent of both Parties.
7.7. Notice. Any notice required or permitted to be given by either Party under this
Agreement shall be sufficient if in writing and hand delivered (including delivery by courier) or sent
by postage prepaid certified mail return receipt requested, as follows:
If to Covered Entity: If to Capital Rx:
Monroe County Attorney's Office Attention: Legal
I I 1112th St. 4408 228 Park Avenue S., Suite 87234,
Key West, FL 33040 New York,New York 10003
7.8. Severability. The Parties agree that if a court determines, contrary to the intent of the
Parties, that any of the provisions or terms of this Agreement are unreasonable or contrary to public
policy, or invalid or unenforceable for any reason in fact, law, or equity, such unenforceability or
validity shall not affect the enforceability or validity of the remaining provisions and terms of this
Agreement. Should any particular provision of this Agreement be held unreasonable or unenforceable
for any reason, then such provision shall be given effect and enforced to the fullest extent that would
be reasonable and enforceable.
7.9. Waiver of Breach. No failure or delay by either Party in exercising its rights under this
Agreement shall operate as a waiver of such rights, and no waiver of any breach shall constitute a
waiver of any prior, concurrent, or subsequent breach.
7.10. Titles. Titles or headings are used in this Agreement for reference only and shall not
have any effect on the construction or legal effect of this Agreement.
7.11. Independent Contractors. For purposes of this Agreement, Covered Entity and Capital
Rx are and will act at all times as independent contractors. None of the provisions of this Agreement
are intended to create, nor shall be deemed or construed to create, any relationship other than that of
- 7 -
independent entities contracting with each other for the purpose of effecting this Agreement. None of
the provisions of this Agreement shall establish or be deemed or construed to establish any
partnership, agency,employment agreement or joint venture between the Parties.
7.12. No Third Party Beneficiaries. It is the intent of the Parties that this Agreement is to be
effective only in regards to their rights and obligations with respect to each other. It is expressly not
the intent of the Parties to create any independent rights in any third party or to make any third-party
beneficiary of this Agreement and no privity of contract shall exist between third parties and each
Party.
Each Party to this Agreement warrants that it has full power and authority to enter into this
Agreement, and the person signing this Agreement on behalf of either Party warrants that he/she
has been duly authorized and empowered to enter into this Agreement.
COVERED ENTITY: CAPITAL RX:
BOARD OF COUNTY COMMISSIONERS
OF MONROE COUNTY,FLORIDA
By: By: /oat A47.ac el
fie: avor eather Carruthers Title: Vice President of Legal
(il q. z-cri o
,, - t ' <e,T: ICE MADOK,CLERK
vl• / /
As Deputy Clerk
VED AS TO FORM AND CONTENT:
fl MONROE COUNTY ATTORNEYS OFFICE .-
6
O *1
Cr:
8-21-2020 - T r)
MO
2 1T1
tD n
0
> r o
- 8 -
CERTIFICATE OF LIABILITY INSURANCE DATE IMMfDDN
YI
164�
020
THIS CERTIFICATE IS ISSUED AS A MATTER OF INFORMATION ONLY AND CONFERS NO RIGHTS UPON THE CERTIFICATE HOLDER. THIS
CERTIFICATE DOES NOT AFFIRMATIVELY OR NEGATIVELY AMEND, EXTEND OR ALTER THE COVERAGE AFFORDED BY THE POLICIES
BELOW, THIS CERTIFICATE OF INSURANCE DOES NOT CONSTITUTE A CONTRACT BETWEEN THE ISSUING INSURER(S), AUTHORIZED
REPRESENTATIVE OR PRODUCER,AND THE CERTIFICATE HOLDER.
IMPORTANT: If the certificate holder is an ADDITIONAL INSURED,the policy(ies)must have ADDITIONAL INSURED provisions or be endorsed.
If SUBROGATION IS WAIVED, subject to the terms and conditions of the policy, certain policies may require an endorsement, A statement on
this certificate does not confer rights to the certificate holder in lieu of such endorsoment(s).
PRODUCER CONTACd
Arthur J, Gallagher Risk Management Services, Iglu. vlAfa FAX
290 Jefferson Park •800-35"005_ A1C be:973-921-2876
Whippany NJ 07981 DR
INSURER(SI AFFORDING COVERAGE NAIC M
DB-72,4491INSURER A!Northfield Insurance Company Compapy 27987
INSURED CAPIRXL-01 INSURER B:Kinsale Insurance CoLnpany 38920
Capital RX Inc
28 Park Ave S Suite 8 87234 INSURER c.Underwriters at_Lloyd's London 15792
Now York NY 10003 INSURER 0, Evanston Insurance Company 35378
INSURER E
INSURER F
COVERAGES CERTIFICATE NUMBER:189066817 REVISION NUMBER
THIS IS TO CERTIFY THAT THE POLICIES OF INSURANCE LISTED BELOW HAVE BEEN ISSUED TO THE INSURED NAMED ABOVE FOR THE POLICY PERIOD
INDICATED, NOTWITHSTANDING ANY REQUIREMENT, TERM OR CONDITION OF ANY CONTRACT OR OTHER DOCUMENT WITH RESPECT TO WHICH THIS
CERTIFICATE MAY BE ISSUED OR MAY PERTAIN, THE INSURANCE AFFORDED BY THE POLICIES DESCRIBED HEREIN IS SUBJECT TO ALL THE TERMS,
EXCLUSIONS AND CONDITIONS OF SUCH POLICIES,LIMITS SHOWN MAY HAVE BEEN REDUCED BY PAID CLAIMS.
INSR TYPE OF INSURANCE A L SUSR POLICY EFF POLICY EXP LIMITS
LTft POLICYNUMBER MLDDI`YYY MM1DONYYY
A X COMMERCIAL GENERAL LIABILITY Y WS414317 312312020 3/23/2021 EACH OCCURRENCE $1,000,000
5AMAGE TO
CLAIMS�MADE [.I OCCUR PREMISES MaRENTE
=rvence $100,000
APPROVED RISK MANAGEMENT MED EXP(Any one person) S5,000
_.. _....... PERSONAL&AOV INJURY $EXCLUDED
GENL AGGREGATE LIMIT APPLIES PER GENERAL AGGREGATE 5 3,000,000
PR r
POLICY,J JET c _, LOC - / PRODUCTS-COMPIOPAGG SEXCiLt1DED
OTHER: S -_
A AUTOMOBILE LIABILITY Y WS41.431.7 I 3/2312020 312312021 COMBINED SINGLE LIMIT $1,000.000
Ea accrdent.
ANY AUTO BODILY INJURY IPer person) S
OWNED SCHEDULED BODILY INJURY{Per aocidantl S
AUTOS ONLY AUTOS
X HIRED IX
NON-OWNED PRO P€RTY DAMAGE S
AUTOS ONLY AUTOS ONLY Per aaadonl-
S
a UMBRELLA LIAR X OCCUR 01001106650 312312020 3/2312021 EACH OCCURRENCE $1,000,000
X1 EXCESS LIAR CLAIMS-MADE AGGREGAT€ S
LIED RETENTIONS _ S
WOreKERSGOMPENSA7ION STATUT ERH
AND EMPLOYERS'L -
AND Y 1 N
ANYPROPFUETORJPARTNEFUEXECUTIVE ❑ N 1 A E.L.EACH ACCIDENT S
O FFIC ERl M E MBE R E X C LUD ED?
(Mandatory In NH) E.L,DISEASE-EA EMPLOYEE S
II yy83,descnbe under
DESCRIPTION OF OPERATIONS below t t I E.L.DISEASE:.POLICY LIMIT S
C E B O MPL219103720 311312020 311312021 Professional Liao 1 MN2 Mil Agar
D Tech MKLVIPDBO00065 5IV2020 51212021 Cyber Liability $1.000,000
DESCRIPTION OF OPERATIONS/LOCATIONS I VEHICLES(ACORD 101,Additional Remarks Schedule,may he attached If more space is required)
Monroe County Board of County Commissioners is an Additional Insured as respects to General Liability And Auto Liability policies,pursuant to and subject to
the policy's terms,definitions,conditions and exclusions.
CERTIFICATE HOLDER CANCELLATION
SHOULD ANY OF THE ABOVE DESCRIBED POLICIES BE CANCELLED BEFORE
THE EXPIRATION DATE THEREOF, NOTICE WILL BE DELIVERED IN
ACCORDANCE WITH THE POLICY PROVISIONS.
Monroe County Board Of County Commissioners,
1100 Simonton St AUTHORIZEOREPRESENTAT
Key West FL 330404
m 1988-2015 ACORD CORPORATION. All rights reserved.
ACORD 25(2016103) The ACORD name and logo are registered marks of ACORD